Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Isenberg

Showing results (1-10 of 186) with videos related to

Pageof 19
Sort By:
Annals of the Rheumatic Diseases|May 28, 2020
Eric Bywaters a life story: 1 June 1910 to 2 April 2003David Isenberg
Current Opinion in Rheumatology|December 4, 2004
Making sure the treatment of myositis does not get "lost in translation"David Isenberg
Arthritis and Rheumatism|May 25, 2010
"Muscles … and bones"David Isenberg
Annals of the Rheumatic Diseases|October 31, 2018
Comment on: 'Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand <i>et al</i>David Isenberg
Annals of the Rheumatic Diseases|November 5, 2015
Further thoughts about the ILLUMINATE studies of tabalumab in SLEDavid Isenberg
Rheumatic Diseases Clinics of North America|August 9, 2005
Mixed connective tissue disease: still crazy after all these yearsJosephine Swanton, David Isenberg
Current Opinion in Pharmacology|July 15, 2004
Anti B cell therapy (rituximab) in the treatment of autoimmune diseasesHanadi Kazkaz, David Isenberg
Clinical Medicine (London, England)|July 11, 2006
Working together to improve rheumatology servicesMatthew Adler, David Isenberg
Annals of the Rheumatic Diseases|May 22, 2014
Vaccines and biologicsIsabel Ferreira, David Isenberg
Lupus|May 26, 2023
A review of the development of gangrene in patients with systemic lupus erythematosus - A 44-year follow-up studyJoana Rua, David Isenberg
Pageof 19

Showing results (1-10 of 186) with videos related to

Sort By:
Pageof 19
Annals of the Rheumatic Diseases|May 28, 2020
Eric Bywaters a life story: 1 June 1910 to 2 April 2003David Isenberg
Current Opinion in Rheumatology|December 4, 2004
Making sure the treatment of myositis does not get "lost in translation"David Isenberg
Arthritis and Rheumatism|May 25, 2010
"Muscles … and bones"David Isenberg
Annals of the Rheumatic Diseases|October 31, 2018
Comment on: 'Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumab' by Eric Morand <i>et al</i>David Isenberg
Annals of the Rheumatic Diseases|November 5, 2015
Further thoughts about the ILLUMINATE studies of tabalumab in SLEDavid Isenberg
Rheumatic Diseases Clinics of North America|August 9, 2005
Mixed connective tissue disease: still crazy after all these yearsJosephine Swanton, David Isenberg
Current Opinion in Pharmacology|July 15, 2004
Anti B cell therapy (rituximab) in the treatment of autoimmune diseasesHanadi Kazkaz, David Isenberg
Clinical Medicine (London, England)|July 11, 2006
Working together to improve rheumatology servicesMatthew Adler, David Isenberg
Annals of the Rheumatic Diseases|May 22, 2014
Vaccines and biologicsIsabel Ferreira, David Isenberg
Lupus|May 26, 2023
A review of the development of gangrene in patients with systemic lupus erythematosus - A 44-year follow-up studyJoana Rua, David Isenberg
Pageof 19